These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15171697)

  • 1. Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation.
    Ma Z; Hung Nguyen T; Hoa Huynh T; Tien Do P; Huynh H
    J Endocrinol; 2004 Jun; 181(3):493-507. PubMed ID: 15171697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bawu decoction () ameliorates benign prostatic hyperplasia in rats.
    Eom JH; Cheon SY; Chung KS; Kim MD; An HJ
    Chin J Integr Med; 2017 Aug; 23(8):611-616. PubMed ID: 27838873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
    Li R; Jia DY; Li Z; Xu DR; Luo SY
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins.
    Huynh H
    Int J Oncol; 2002 Jun; 20(6):1297-303. PubMed ID: 12012013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
    Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
    Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
    Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
    Park BK; Kim CW; Kwon JE; Negi M; Koo YT; Lee SH; Baek DH; Noh YH; Kang SC
    Pharm Biol; 2019 Dec; 57(1):90-98. PubMed ID: 30724641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinemia: comparison with finasteride.
    Van Coppenolle F; Le Bourhis X; Carpentier F; Delaby G; Cousse H; Raynaud JP; Dupouy JP; Prevarskaya N
    Prostate; 2000 Apr; 43(1):49-58. PubMed ID: 10725865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
    Sirinarumitr K; Johnston SD; Kustritz MV; Johnston GR; Sarkar DK; Memon MA
    J Am Vet Med Assoc; 2001 Apr; 218(8):1275-80. PubMed ID: 11330612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model.
    Afriyie DK; Asare GA; Bugyei K; Adjei S; Lin JM; Peng J; Hong ZF
    J Ethnopharmacol; 2014 Nov; 157():90-8. PubMed ID: 25256687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
    Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor.
    Prahalada SR; Keenan KP; Hertzog PR; Gordon LR; Peter CP; Soper KA; van Zwieten MJ; Bokelman DL
    Urology; 1994 May; 43(5):680-5. PubMed ID: 7513109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
    J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
    Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
    J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
    Justulin LA; Acquaro C; Carvalho RF; Silva MD; Felisbino SL
    Int J Androl; 2010 Jun; 33(3):489-99. PubMed ID: 19490185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tomato lipidic extract plus selenium decrease prostatic hyperplasia, dihydrotestosterone and androgen receptor expression versus finasteride in rats.
    Arias-Chávez DJ; Mailloux-Salinas P; Ledesma-Aparicio J; Campos-Pérez E; Medina-Campos ON; Pedraza-Chaverri J; Bravo G
    World J Urol; 2023 Oct; 41(10):2793-2799. PubMed ID: 37659980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog.
    Crescioli C; Ferruzzi P; Caporali A; Mancina R; Comerci A; Muratori M; Scaltriti M; Vannelli GB; Smiroldo S; Mariani R; Villari D; Bettuzzi S; Serio M; Adorini L; Maggi M
    Endocrinology; 2003 Jul; 144(7):3046-57. PubMed ID: 12810561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.